The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma
2.
Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.
3.
Base Treatment Decisions in Metastatic Breast Cancer on Presence of ESR1 Mutations
4.
Elder Abuse: Red Flags to Look Out For While Receiving Care.
5.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
1.
Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options
2.
Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options
3.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
4.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
5.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
3.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation